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Kinetic una )'sis of the hydrtd~sis of the I~ptide lI.Val,Ser.GIn,Asn.Tyr*Pro.ll¢.VaI.GIn.Nll~ and its analo$,t obtainctl by varyinll the !ength and 
introduein= substitutions at the P, site was carried out with t~flh HIV.I and ItlV.2 prolein~se~. Deletion or ih¢ t~rmlnal Vtd ~nd Gin had only 
metier|tie effect on ilia ~uhstrltte hydroly~h, while the d~lation of tli.c P.~. Set ~ts well as P; V, I  Ilrcatly reduwd the substrata hydrolysis. Thi~ is 
pr~dicled to bc due to the loss of Intera,:tions betwoen main ~h~ins of the en,~yme ~ntl thtt substrata. $=bstitution of tile P,~ Ser h:,, amino =raids 
having high frequency 0f occurrenc~ in//turns resulted in llood substratcs, while larlle ~mino lteids were unfavorable in thi~ position. The two 
prntai=mses acted similarly, except for substrates havini! TItr, Val and Let= substitutions, which were I~=iler ,o;ommodated in the FIlV.2 substrata 
bindin$ pocket, 
I=llV prot¢inasc; Type I und 2; Oli~op~pllde substrat¢; Enzyme kinetics 
I. INTRODUCTION 
Since the retroviral proteinase (PR) of the human im- 
munodeficiency virus type-I (HIV.I), and type-2 
(HIV.2) is essential for virus replication [1], the HIV 
PRs are considered potential targets for chemotherapy 
[21, Tile polyprotein processing by retroviral PRs, in- 
cluding HIV-I PR, seems to be restricted to the junc- 
tions of the protein domains of Gag and Gag-PoI poly- 
proteins [3,4], However, it is difficult to  determine a 
consensus ubstrata sequence for the retroviral PRs. 
Although the substrata specificity of retroviral pro- 
teinases may partially depend on the proper substrata 
conformation, the amino acid sequence may have an 
important role in determining the cleavage sites. A bet. 
tar understanding of the substrata Specificity may help 
to design potent inhibitors that are effective against 
both HIV-I and HIV.2 PRs, Recently, kinetic studies 
were carried out on oligopeptide substrates with single 
amino acid substitutions [5-8]. Here we report a kinetic 
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and modeling study on the S~: site (notation according to 
Schechter and Berger [9]) of HIV PRs. Variations in 
substrata length were also analyzed for both. pro- 
teinases, 
2, MATERIALS AND METHODS 
Rccombhlant l.-llVil PR [I0] and chem Ca y synthesized HIV-2 PR 
[I I,!2} were used~ Active enzyme content was determined by active 
site titration using ',l potent transition-state nalog inhibitor [13]. 
Oligopeptides with amida C-termini were synthesized aqd chorea. 
terlzed as described [11], The assays were performed in 0,25 M 
potassium pltosphata buffer, pH S,6, containing 7,5070 glycerol, 5 mM 
dithiothreitol, I mM E DTA, 0,2°7o nonidet P.40 and 2 M NaCI, The 
reaction mixture was ilicubated at 37°C for 1 h, and the reaction was 
• stopped by the addition of guanidine-HCl (6M final concentration), 
"l'he cleavage product peaks were detected by reversed-phase HPt.C 
[1 I], integrated, and the kinetic parameters were determined at less 
than 20°70 substratc turnover by fitting the data to the Michaelis. 
Menten equation using the Gauss.Newton iteration method. The 
computer program (Enz 5,0) was written and kindly provided by M, 
Fivash and J. Racheff rom the Data Management Services lnc,, NCI- 
FCRDC, Frederick, The asymptotic standard errors were 5-20°7o, 
The atomic coordinates from the crystal structure of HIV.I PR 
with different inhibitors [14-16] were examined on an Evans and 
Sutherland PS390 molecular graphics system using the program, 
FRODO [!7]. The HIV-2 PR coordinates were obtained by molecular 
modeling (A. Gustchina nd 1, Weber, to be published elsewhere), It 
was possible to place the modeled side chains in identical or closely 
similar positions tO those in the inhibitor co-crystal structures, The 
amino acid side chains at P.~ were examined in both HIV.I and HIV-2 
PR structures. The c0nformational flexibility of interacting side 
chains in substrata nd in the enzyme was tested by rotatingaround 
single bonds in the side chains of residaes to model the process of 
substrata binding as it might occur in solution. This approach was us. 
edto estimate the degree of adjustment required for accommodation 
of particular esidues in the binding site of the enzyme, 
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3. RESULTS AND DISCUSSION 
A nonapeptide, H.VaI-Ser.GIn.Asn.Tyr*Pro-lle. 
Val.GIn-NHa (designated as SP .2 | l ) ,  with the sequence 
or the cleavage site at the junction of tl~e matrix and 
capsid proteins in HIV-I  was found to be a good 
substrate for both HIV-I and HIV.2 PRs [I0-12]. To 
determine tl~e minimal length of the substrate for the 
HIV PRs, ibis l~ptide was truncated at both Ihe N- and 
C-termini (Table I), The frost dramatic decrease in 
catalytic onstants (k,~,,,/¢~,."K.,) were obtained by the 
elimination of P~ Ser or P~' Val. The minimal substrate 
requirement for both enz~,mes was six amino acid 
residues, from P.~ to Pa' or from P~ to P~', Shorter pep. 
tides were not hydrolyzed, and were tested as inhibitors 
o fSP.21 i cleavage by HIV-2 PR (Table l), The observ- 
ed lCso values suggest hat some of the shorter peptides 
could bind to the enzyme with affinity similar to the 
longer substrates, although only in nonproductive 
manner, 
The crystal structures of HIV.I Pg with various in- 
hibitors [14-16,18,19] show that the inhibitor is bound 
in an extended beta conformation, as was predicted by 
molecular modeling [20]. The conformation of  the in- 
hibitor is maintained by a series of hydrogen bond in- 
teractions between the C = 0 and NH groups of the in- 
hibitor and atoms of the PR. dimer (Fig, 1), The amino 
acid side chains of  inhibitors lie in successive subsites of 
the PR dimer, It was proposed by Gustchina nd Weber 
[21] that the main chain-main chain interactions be- 
tween PR and the substrate were important for produc- 
tive binding and catalysis. These interactions are in- 
dependent of the particular residues forming the 
substrate or inhibitor peptide, Although there is some 
symmetry around the scissile bond, the hydrogen ben. 
ding pallern is asymmetric (Fig. 1). While Oly-4g NH in 
the flexible flap of one subtmit interacts with the C - 0 
of Pa, Gly.48' NH Interacts with P~' C ,, O. The loss oP 
these interactions is predicted to be responsible for the 
dramatic decrease in catalytic efficiency on removing 
the P.= and P~' residues, In contrast to P.~ and Pj ' ,  Ps 
and P.=' do not appear to be crucial for efficient 
substrate hydrolysis, These amino acids may interact 
with the main chain of the enzyme, however, these in- 
teractions are not part of the continuous beta sheets 
(Fig. 1), Our results about the minimum length of 
substrate are in accordance with those of Oarke eta l .  
[22] and Moore et al, I231 for the HIV.I PR using 
substrates based on the same cleavage site, Studies in 
other laboratories have shown efficient cleavage of pep- 
tides starting at P~ [8,241, however, one of these has 
Art  at P~ which has many possibilities of additional in- 
teractions, and the other was extended to Ps' ,  The 
catalytic properties are expected to depend on the 
specific combination of amino acids forming the 
substrate, in addition to the interactions involving main 
chain atoms, 
To further explore the role oF P~ in the substrate 
hydrolysis, various amino acids were introduced into 
the P4 position of SP-211. The kinetic parameters ob- 
tained with HIV-I and I-[IV-2 PRs are listed in Table II. 
The most obvious effect is that residues at P.~ witl~ high 
tendency to form beta turns (Set, Gly, Asp, Asn, Pro; 
[25]) show high catalytic constants (kent and k~a,/K,n) 
compared to the others. It has been suggested that the 
P4 position in retroviral cleavage sites is preferentially a 
turner or helix breaker [26]. These results again sug- 
gest that it is important for the substrate to assume an 
Table 1 
Cleavage of oligopeptides representing the cleavage site between the matrix al~d capsid proteins of HIV.I by HIV,I 
and HIV-2 PRs 
Peptide HIV.I PR HIV-2 PR 
K,,, k¢~, k~JK,. K,. k~.~,, k~.VK,. ICsu u 
(raM) (s" ') (raM" ' ,s ' ' )  (raM) (s- i) (mM'"s- i) (raM) 
VSQNY*PIVQ" 0.15 6,8 45,3 0,18 6.2 34.4 
SQNY*PIVQ 0,78 15.7 20. I 0,61 12.0 19.7 
QNY*PIVQ 0.91 1.6 1.8 1.04 I, 1 1. I 
NY*PIVQ 0 0 1,39 
Y*PIVQ 0 0 0,55 
VSQNY*PIV 0,12 7,9 65.8 0.11 5,0 45,4 
SQNY*PIV 0,53 13,5 25,4 0,23 3,6 15,6 
QNY*PIV 0,86 1.0 1,2 0.19 0.3 1,6 
NY*PIV 0 0 0,30 
Y*PIV 0 0 0,13 
VSQNY*PI <0.5 <0.5 
SQNY*PI <0,5 <0.5 
QNY*PI 0 0 > 1,50 
a Substrate designated asSP-211 [10-12]. Scissile bond is marked with asterisk 
" ICso values measured as inhibition of the cleavage of SP-21 l. Smaller peptides which were also tested and were net 
hydrolyzed: NY*PI; VSQNY*P; SQNY*P; QNY*P; NY*P; Y'P, These peptides (except the dipeptide) were also 
able to inhibit the cleavage of VSQNY*PIVQ, with ICso> 1.5 mM 
? 
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Fig. '!. Schcmndc representation of tire put~tlive interactions of  the substrale, VSQNY'PIVQ, (SP.21 I. P.~-P#' ) in the HIV.I PR blmling site, The 
PR residues that form hydrogen bond interactions with the substrate are shown. Dashed lines indicate hydrogen bond inIeracdons. The residues 
from Ihe second suboniI ht ~he PR direct are Indtcn[ed by it prince. In[etacdons are observed in eryslnl slructurcs [ 14-}61 whh the e,xcepdon: of  
P4' wltieh was predicted by modeling, Two short continuous # sheets are formed by each C = O and NH group of subs~rate residue,= P.~ Io P, and 
P=' to Ps' with the flap residues 48-50 and residues 27-29 of each PR subunh. The peptide C ,=, O and NH groups ruriher trent cite scissi/e bond 
¢han P.~ and P~' do not form continuous beta sheet interactions with the flaps. 
extended B conformation within the PR binding site, 
and alter conformation on the surface of the PR  dimer 
in order to connect the folded portions of the polypcp- 
tide substrate. The $4 subsite isa well-defined pocket: 
Asp-29, Asp-30 and Ile/Val.47 were found to be its 
mo~t important components (Fig. 2). As was originally 
predicted from modeling studies [20], $4 most easily ac- 
commodates smaller amino acid side chains. $4 does not 
readily accommodate side chains that are branched at 
the B carbon atom due to the proximity of lle-4'7 in 
HIV-I PR, This was tested by rotating the side chain of 
PR residue 47 in order to explore its conformational 
flexibility (Fig. 2). Iie-47 in HIV-I in some conforma- 
tions can interfere with the binding of residues with 
branched side chains at P4 (Fig, 2), This explains the 
poor kinetic values for branched amino acids like Thr, 
Val and lle, In the case of Thr. the potential of forming 
hydrogen bonds similar to those of the OH of Set may 
partially compensate for this effect, 
In most respects, the results for H[V-2 PR are similar 
Table II 
Kinetic parameters determined for substrates l~aving VXQNY*PIVQ structure 
Xaa HIV.I PR HIV.2 PR 
g,,, I<~= kc.~lK., K.~ I:~,. k~.,IK,. 
(raM) (s "l ) (mM-1 's  -I ) (mM) (s "t ) (raM "z ,s "~) 
Sera 0.15 6,8 45.3 0,18 6,2 34,4 
Thr 1.5 3.0 2,0 1,0 3,] 3.1 
Gly 0,6 I0,3 17.2 0,8 lO.S 13,l 
Asp 1,5 10,0 6,6 1,4 14,5 10.4 
Asn 1.0 8.1 8,1 1,0 6.6 6.6 
Pro 0.28 6,3 22,5 0.40 4.7 11.7 
Arg 1,3 2.7 2.1 1,5 2,2 1.5 
Lys 1,4 1,2 0,9 1,2 1,3 I .I 
Met 0,9 0 ,9  1,0 1,0 0,9 0.9 
Ala 0,7 3,1 4,4 0.8 2,4 3.0 
Leu 0,40 0.06 0,2 0,6 0,6 1.0 
lle N,D. 0,06 N,D. N,D, 0,10 N,D, 
Phe N,D. 0.14 N.D. N,D. 0,20 N,D. 
Val N,D. 0.08 N.D. N.D. 0.50 N,D. 
a Corresponds to the original substrate (SP.211) representing the cleavage site 
between the matrix and capsid proteins in HIV-I,  N,D, = not determined. 
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Fig, 2, Stereo view or Thr at P,~ in subsile S., or HIV PRs, Solid honds indicate tile residues (Jr HIV.2 PR, open bonds Indicate the equiwllen! 
r~:x~d.¢~, cal' I-IIV. I P~., I[e.47 i~ shown also in thin lines to indicate a posit ion in whi¢lt it would h~ve extremely poor contacts widt Thr at P,=, Dashed 
lines Indicate potential hydro|on bond intera¢ti0ns, 
to those for HIV-1 PR., Examination o1' the model of 
HIV.2 PR showed that the only difference in $4 is that 
residue 47 is the smaller Val (Fig. 2), which may explain 
the better kinetic parameters for branched anaino acids. 
However, the most pronou:~ced difference was ~b';ain- 
ed with the Leu-containing suostrate, Which has abuu( 
I0 times higher k~.=u for HIV-2 than for HIV-I PR, 
Ile/Val-47 is also part of the P= substrate-binding 
pocket, this may explain the better k~., value for a 
substrate containing Leu and P2 which has been noted 
for HIV-2 PR compared with HIV-I PR [8], 
Recently, extensive studies were carried out in- 
vestigating the preference for the P2 of HIV-I PR [5] 
and P : -  P~ positions for both PRs [6-8]. The crucial 
role of the Pz and P=' positions were suggested [5,8], 
Our results uggest that the P4 position may also be im- 
portant for proper catalytic activity, and unfavorable 
amino acids (or protecting roups in artificial peptides) 
may result in a substantial decrease of substrate-binding 
and hydrolysis rate. 
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